Cargando…
Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236980/ https://www.ncbi.nlm.nih.gov/pubmed/35780073 http://dx.doi.org/10.1016/j.ejim.2022.06.018 |
| _version_ | 1784736662064988160 |
|---|---|
| author | Dal-Ré, Rafael Caplan, Arthur L Voo, Teck Chuan |
| author_facet | Dal-Ré, Rafael Caplan, Arthur L Voo, Teck Chuan |
| author_sort | Dal-Ré, Rafael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9236980 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92369802022-06-28 Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable Dal-Ré, Rafael Caplan, Arthur L Voo, Teck Chuan Eur J Intern Med Ideas and Opinions European Federation of Internal Medicine. Published by Elsevier B.V. 2022-09 2022-06-28 /pmc/articles/PMC9236980/ /pubmed/35780073 http://dx.doi.org/10.1016/j.ejim.2022.06.018 Text en © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Ideas and Opinions Dal-Ré, Rafael Caplan, Arthur L Voo, Teck Chuan Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title | Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title_full | Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title_fullStr | Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title_full_unstemmed | Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title_short | Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
| title_sort | participants’ informed consent in adaptive, platform drug trials in hospitalized covid-19 patients: not all approaches are ethically acceptable |
| topic | Ideas and Opinions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236980/ https://www.ncbi.nlm.nih.gov/pubmed/35780073 http://dx.doi.org/10.1016/j.ejim.2022.06.018 |
| work_keys_str_mv | AT dalrerafael participantsinformedconsentinadaptiveplatformdrugtrialsinhospitalizedcovid19patientsnotallapproachesareethicallyacceptable AT caplanarthurl participantsinformedconsentinadaptiveplatformdrugtrialsinhospitalizedcovid19patientsnotallapproachesareethicallyacceptable AT vooteckchuan participantsinformedconsentinadaptiveplatformdrugtrialsinhospitalizedcovid19patientsnotallapproachesareethicallyacceptable |